Skip to main content
. 2023 Jul 7;10:1163817. doi: 10.3389/fmed.2023.1163817

Table 2.

Clinical presentation of both groups.

Types of symptoms and signs Total patients n = 314 Epi group n = 107 (34.1%) Non-epi group n = 207 (65.9%) p-value
Clinical presentation on arrival
Cardiovascular
Hypotension-no. (%) 142 (45.2) 61 (57.01) 81 (39.1) 0.03*
Chest pain-no. (%)a 30 (9.6) 11 (10.3) 19 (9.2) 0.75
Cutaneous
Skin reaction-no. (%) 273 (88.4) 90 (84.1) 183 (88.4) 0.28
Angioedema-no. (%)a 14 (4.5) 6 (5.6) 8 (3.9) 0.57
Respiratory
Respiratory-no. (%) 179 (57.0) 58 (54.2) 121 (58.5) 0.47
Airway compromise-no. (%) 50 (6.9) 48 (44.9) 2 (0.9) <0.01*
Gastrointestinal
N/V-no. (%) 47 (15.0) 13 (12.1) 34 (16.4) 0.31
Diarrhoea-no. (%)a 16 (5.1) 5 (4.7) 11 (5.3) 1.00
Neurological
Altered consciousness-no. (%) 81 (25.8) 58 (54.2) 23 (11.1) <0.01*
Dizziness-no. (%)a 23 (7.2) 9 (8.4) 14 (6.7) 0.60

Continuous data are expressed as the means ± SDs, and categorical data are expressed as numbers (%).

a

Fisher’s exact test *p < 0.05 h, hour; N/V, nausea/vomiting.